$26.99▲0.00 (0.00%)Earnings · Nov 26
Extended:$26.99+0.00 (+0.00%)· 9:50 PM ET
Fisher & Paykel Healthcare Corporation Limited (FSPKF)
R&D Expense Growth
4.83%
Fiscal year · Period ending:

FSPKF R&D Expense Growth
Latest reported4.83%period ending
Latest reported4.83%period ending
FSPKF FY R&D Growth (YoY) (0.00% → 4.83%)
Latest values, visible window
High-resolution chart · PNG
What is r&d expense growth?
Year-over-year research & development expense growth.
FSPKF r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 4.8306% | |
| 14.4803% | |
| 13.712% | |
| 13.1818% | |
| 12.6554% | |
| 15.3586% | |
| 13.3022% | |
| 4.126% | |
| 7.2178% | |
| 15.1832% | |
| 23.7471% | |
| 12.6876% | |
| 2.4056% | |
| 6.9088% | |
| 0.1151% | |
| 16.0845% | |
| 32.2085% | |
| 23.8248% | |
| 22.6983% | |
| 12.77% | |
| 14.9026% | |
| 0% | |
| 0% | |
| -100% | |
| 18.9593% | |
| 0% |
Explore More
FSPKF Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance